Tumour marker CA15-3: possible uses in the routine management of breast cancer

By Tomlinson I.P.M.   Whyman A.   Barrett J.A.   Kremer J.K.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 899-902

Elsevier

Access to resources Recommend Favorite

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

By D’Alessandro R.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 1, 2001-07 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite

Multicentric breast cancer: clonality and prognostic studies

By Eeles R.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 703-716

Springer Publishing Company

Access to resources Recommend Favorite

Breast Conservation in Women with Multifocal-Multicentric Breast Cancer: Is It Feasible?

By Bauman Laura   Barth Richard   Rosenkranz Kari  

Annals of Surgical Oncology, Vol. 17, Iss. 3, 2010-10 ,pp. : 325-329

Springer Publishing Company

Access to resources Recommend Favorite

Serum Tumor Marker CA 15.3 and Stage are the Two Most Powerful Predictors of Survival in Primary Breast Cancer

By Kumpulainen E.J.   Keskikuru R.J.   Johansson R.T.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 95-102

Springer Publishing Company

Access to resources Recommend Favorite